Cargando…
Zellweger spectrum disorders: clinical manifestations in patients surviving into adulthood
INTRODUCTION: We describe the natural history of patients with a Zellweger spectrum disorder (ZSD) surviving into adulthood. METHODS: Retrospective cohort study in patients with a genetically confirmed ZSD. RESULTS: All patients (n = 19; aged 16–35 years) had a follow-up period of 1–24.4 years (mean...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710674/ https://www.ncbi.nlm.nih.gov/pubmed/26287655 http://dx.doi.org/10.1007/s10545-015-9880-2 |
_version_ | 1782409839459172352 |
---|---|
author | Berendse, Kevin Engelen, Marc Ferdinandusse, Sacha Majoie, Charles B. L. M. Waterham, Hans R. Vaz, Frédéric M. Koelman, Johannes H. T. M. Barth, Peter G. Wanders, Ronald J. A. Poll-The, Bwee Tien |
author_facet | Berendse, Kevin Engelen, Marc Ferdinandusse, Sacha Majoie, Charles B. L. M. Waterham, Hans R. Vaz, Frédéric M. Koelman, Johannes H. T. M. Barth, Peter G. Wanders, Ronald J. A. Poll-The, Bwee Tien |
author_sort | Berendse, Kevin |
collection | PubMed |
description | INTRODUCTION: We describe the natural history of patients with a Zellweger spectrum disorder (ZSD) surviving into adulthood. METHODS: Retrospective cohort study in patients with a genetically confirmed ZSD. RESULTS: All patients (n = 19; aged 16–35 years) had a follow-up period of 1–24.4 years (mean 16 years). Seven patients had a progressive disease course, while 12 remained clinically stable during follow-up. Disease progression usually manifests in adolescence as a gait disorder, caused by central and/or peripheral nervous system involvement. Nine were capable of living a partly independent life with supported employment. Systematic MRI review revealed T2 hyperintense white matter abnormalities in the hilus of the dentate nucleus and/or peridentate region in nine out of 16 patients. Biochemical analyses in blood showed abnormal peroxisomal biomarkers in all patients in infancy and childhood, whereas in adolescence/adulthood we observed normalization of some metabolites. CONCLUSIONS: The patients described here represent a distinct subgroup within the ZSDs who survive into adulthood. Most remain stable over many years. Disease progression may occur and is mainly due to cerebral and cerebellar white matter abnormalities, and peripheral neuropathy. |
format | Online Article Text |
id | pubmed-4710674 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-47106742016-01-19 Zellweger spectrum disorders: clinical manifestations in patients surviving into adulthood Berendse, Kevin Engelen, Marc Ferdinandusse, Sacha Majoie, Charles B. L. M. Waterham, Hans R. Vaz, Frédéric M. Koelman, Johannes H. T. M. Barth, Peter G. Wanders, Ronald J. A. Poll-The, Bwee Tien J Inherit Metab Dis Original Article INTRODUCTION: We describe the natural history of patients with a Zellweger spectrum disorder (ZSD) surviving into adulthood. METHODS: Retrospective cohort study in patients with a genetically confirmed ZSD. RESULTS: All patients (n = 19; aged 16–35 years) had a follow-up period of 1–24.4 years (mean 16 years). Seven patients had a progressive disease course, while 12 remained clinically stable during follow-up. Disease progression usually manifests in adolescence as a gait disorder, caused by central and/or peripheral nervous system involvement. Nine were capable of living a partly independent life with supported employment. Systematic MRI review revealed T2 hyperintense white matter abnormalities in the hilus of the dentate nucleus and/or peridentate region in nine out of 16 patients. Biochemical analyses in blood showed abnormal peroxisomal biomarkers in all patients in infancy and childhood, whereas in adolescence/adulthood we observed normalization of some metabolites. CONCLUSIONS: The patients described here represent a distinct subgroup within the ZSDs who survive into adulthood. Most remain stable over many years. Disease progression may occur and is mainly due to cerebral and cerebellar white matter abnormalities, and peripheral neuropathy. Springer Netherlands 2015-08-19 2016 /pmc/articles/PMC4710674/ /pubmed/26287655 http://dx.doi.org/10.1007/s10545-015-9880-2 Text en © The Author(s) 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Berendse, Kevin Engelen, Marc Ferdinandusse, Sacha Majoie, Charles B. L. M. Waterham, Hans R. Vaz, Frédéric M. Koelman, Johannes H. T. M. Barth, Peter G. Wanders, Ronald J. A. Poll-The, Bwee Tien Zellweger spectrum disorders: clinical manifestations in patients surviving into adulthood |
title | Zellweger spectrum disorders: clinical manifestations in patients surviving into adulthood |
title_full | Zellweger spectrum disorders: clinical manifestations in patients surviving into adulthood |
title_fullStr | Zellweger spectrum disorders: clinical manifestations in patients surviving into adulthood |
title_full_unstemmed | Zellweger spectrum disorders: clinical manifestations in patients surviving into adulthood |
title_short | Zellweger spectrum disorders: clinical manifestations in patients surviving into adulthood |
title_sort | zellweger spectrum disorders: clinical manifestations in patients surviving into adulthood |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710674/ https://www.ncbi.nlm.nih.gov/pubmed/26287655 http://dx.doi.org/10.1007/s10545-015-9880-2 |
work_keys_str_mv | AT berendsekevin zellwegerspectrumdisordersclinicalmanifestationsinpatientssurvivingintoadulthood AT engelenmarc zellwegerspectrumdisordersclinicalmanifestationsinpatientssurvivingintoadulthood AT ferdinandussesacha zellwegerspectrumdisordersclinicalmanifestationsinpatientssurvivingintoadulthood AT majoiecharlesblm zellwegerspectrumdisordersclinicalmanifestationsinpatientssurvivingintoadulthood AT waterhamhansr zellwegerspectrumdisordersclinicalmanifestationsinpatientssurvivingintoadulthood AT vazfredericm zellwegerspectrumdisordersclinicalmanifestationsinpatientssurvivingintoadulthood AT koelmanjohanneshtm zellwegerspectrumdisordersclinicalmanifestationsinpatientssurvivingintoadulthood AT barthpeterg zellwegerspectrumdisordersclinicalmanifestationsinpatientssurvivingintoadulthood AT wandersronaldja zellwegerspectrumdisordersclinicalmanifestationsinpatientssurvivingintoadulthood AT pollthebweetien zellwegerspectrumdisordersclinicalmanifestationsinpatientssurvivingintoadulthood |